CITIUS ONCOLOGY, INC. (CTOR) Net income 2022–2025
CITIUS ONCOLOGY, INC. (CTOR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$24.8MFY2025 · since FY2022: $380,811 → -$24.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.8M | -17.1% |
| FY2024 | -$21.1M | -974.2% |
| FY2023 | $2.4M | +535.3% |
| FY2022 | $380,811 | — |
Source: SEC XBRL filings · For reference only · Not investment advice